Gangneung Asan Hospital is a tertiary referral hospital in Gangneung, South Korea. It was established by Asan Foundation and its founder Chung Ju-yung. It is the 2nd largest member hospital of Asan Health Network which consists of 8 hospitals including Asan Medical Center in Seoul since it opened in 1996.

There are 822 beds in Gangneung Asan Hospital.

During the past decade, Gangneung Asan Hospital conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gangneung Asan Hospital" #1 sponsor was "Seung-Jung Park" with 28 trials, followed by "Jung-min Ahn" with 3 trials sponsored, "Ajou University School of Medicine" with 2 trials sponsored, "Asan Medical Center" with 2 trials sponsored and "CardioVascular Research Foundation, Korea" with 2 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gangneung Asan Hospital" #1 collaborator was "CardioVascular Research Foundation, Korea" with 34 trials as a collaborator, "Abbott" with 3 trials as a collaborator, "Medtronic" with 3 trials as a collaborator, "Korean Cancer Study Group" with 2 trials as a collaborator and "Abbott Medical Devices" with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Gangneung Asan Hospital" are "Coronary Artery Disease" (31 trials), "Coronary Disease" (4 trials), "Cardiovascular Diseases" (3 trials), "Acute Myocardial Infarction" (2 trials) and "Alcoholic Cirrhosis" (2 trials). Many other conditions were trialed in "Gangneung Asan Hospital" in a lesser frequency.

Most popular intervention types in "Gangneung Asan Hospital" are "Device" (25 trials), "Drug" (22 trials), "Procedure" (5 trials), "Biological" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Aspirin,Clopidogrel" (3 trials), "Cypher" (3 trials), "Aspirin monotherapy" (2 trials), "Cellgram-LC" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Gangneung Asan Hospital" are 60 trials for "All" genders.

Currently, there are NaN active trials in "Gangneung Asan Hospital". undefined are not yet recruiting, 12 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Gangneung Asan Hospital, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Gangneung Asan Hospital, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 22 trials, and there were also 4 trials that are defined as “Not Applicable".